Trademark: MEDIGENE 1984905
Word
MEDIGENE
ID
1984905
Trademark Type
Figurative, Fancy
Status
Protected: Registered/protected
Application Date
17 July 2018
Registration Date
17 July 2018
Renewal Date
17 July 2028
Owner(s)
Service
Spruson & Ferguson
Goods and Services:
Class 5:
Pharmaceutical and veterinary preparations; serums; test kits (diagnostic preparations for medical purposes) for determining the type/existence of a tumour in a patient; diagnostic and therapeutic preparations (mixtures of therapeutically active cells in a suitable medium), in particular produced using molecular biological, biotechnological and genetic methods.
Pharmaceutical and veterinary preparations; serums; test kits (diagnostic preparations for medical purposes) for determining the type/existence of a tumour in a patient; diagnostic and therapeutic preparations (mixtures of therapeutically active cells in a suitable medium), in particular produced using molecular biological, biotechnological and genetic methods.
Class 42:
Services in molecular biology, namely research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; development of test methods and test kits; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumour therapy; development of tumour markers; development of diagnostic and therapeutic antibodies; cell analyses; development of individualised medicine, development of treatment plans and therapy adapted for individual patients.
Services in molecular biology, namely research and development in the field of medical and veterinary diagnosis and treatment using molecular biological, biotechnological and genetic methods, and in the field of screening for compounds with pharmaceutical properties; development of test methods and test kits; development of adoptive T cell therapy; development of DC vaccines; development of cellular tumour therapy; development of tumour markers; development of diagnostic and therapeutic antibodies; cell analyses; development of individualised medicine, development of treatment plans and therapy adapted for individual patients.